Stanley-Laman Group’s Imperva, Inc. IMPV Stock Holding History

Stanley-Laman Group’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-109,507	Closed	-$5.09M	–	314
2018 Q3	$5.09M	Sell	109,507 -9,441	-8%	-$457K	1.25%	19
2018 Q2	$5.74M	Sell	118,948 -3,866	-3%	-$185K	1.29%	16
2018 Q1	$5.32M	Sell	122,814 -2,197	-2%	-$98.7K	1.21%	16
2017 Q4	$4.96M	Buy	125,011 +109,461	+704%	+$4.56M	1.07%	25
2017 Q3	$675K	Buy	+15,550	New	+$710K	0.18%	137

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Stanley-Laman Group's IMPV Position: Q4 2018 in Review

Stanley-Laman Group sold out of Imperva, Inc. (IMPV) in Q4 2018, closing a stake of 109,507 shares — an estimated $5.09M sold.

Stanley-Laman Group first reported a position in IMPV in Q3 2017 and held it in 5 quarters. The position peaked at $5.74M in Q2 2018. 162 funds tracked by Wall St. Rank hold IMPV as of Q4 2018.

Stanley-Laman Group reported no remaining Imperva, Inc. position as of Q4 2018 after selling out during the quarter.
Stanley-Laman Group sold 109,507 Imperva, Inc. shares in Q4 2018, an estimated $5.09M.
Stanley-Laman Group first reported a position in Imperva, Inc. in Q3 2017 and held it in 5 quarters.
Stanley-Laman Group's Imperva, Inc. position peaked at $5.74M in Q2 2018.
162 funds tracked by Wall St. Rank held Imperva, Inc. as of Q4 2018.

Based on Stanley-Laman Group's 13F filing for Q4 2018, filed 7 Feb 2019.